Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information
Phenol styrenated epoxidised [EC No. 935-721-8] is mutagenic in the bacterial gene mutation assay (Ames, OECD 471). No mutagenic activity was found in the corresponding gene mutation assay in mammalian cell culture (HPRT, OECD 473).
Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2012, July 17 - 2012, Sep 19
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP study according to guidelines
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
not applicable
Species / strain / cell type:
E. coli WP2 uvr A
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
Rat liver homogenate metabolising system (10 % liver S9 in standard co-factors
Test concentrations with justification for top dose:
Preliminary Toxicity Test: 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500, 5000 µg/plate
Mutation Test (Experiment 1): 5, 15, 50, 150, 500, 1500, 5000 µg/plate in triplicate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Dimethyl sulphoxide
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water at 50 mg/ml but was fully miscible in
dimethyl sulphoxide at the same concentration in solubility checks performed in-house.
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
N-ethyl-N-nitro-N-nitrosoguanidine
benzo(a)pyrene
other: 2-Aminoanthracene
Remarks:
see details below
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)
- Preliminary toxicity test: The test was performed by mixing 0.1 ml of bacterial culture (TA100 or WP2uvrA), 2 ml of molten, trace histidine or
tryptophan supplemented, top agar, 0.1 ml of test item formulation and 0.5 ml of S9-mix or phosphate buffer and overlaying onto sterile plates of Vogel-Bonner Minimal agar (30 ml/plate).
Ten concentrations of the test item formulation and a vehicle control (dimethyl sulphoxide) were tested.
After approximately 48 hrs incubation at 37°C the plates were assessed for numbers of revertant colonies using a colony counter and examined
for effects on the growth of the bacterial background lawn.

- Mutation Test (Experiment 1): Aliquots (0.1 ml) of one of the bacterial cultures were dispensed into sets of test tubes followed by 2 ml of molten,
trace histidine or tryptophan supplemented, top agar, 0.1 ml of the vehicle, test item formulation or positive control and either 0.5 ml of S9-mix or phosphate buffer.
The contents of each test tube were mixed and equally distributed onto the surface of Vogel-Bonner Minimal agar plates (one tube per plate).
This procedure was repeated, in triplicate, for each bacterial strain and for each concentration of test item both with and without S9-mix.
All of the plates were incubated at 37°C for approximately 48 hours and the frequency of revertant colonies assessed using a colony counter.

NUMBER OF REPLICATIONS: 3 per dose level, with and without metabolic activation (+S9 and -S9)

DETERMINATION OF CYTOTOXICITY
- Method: colony growth (background lawn)
Evaluation criteria:
Criteria for determining a positive result: Any, one, or all of the criteria can be used to determine the overall result of the study:
- A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby (1979)).
- A reproducible increase at one or more concentrations.
- Biological relevance against in-house historical control ranges.
- Statistical analysis of data as determined by UKEMS [Mahon et al (1989)].
- Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response).
- A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.

The reverse mutation assay may be considered valid if the following criteria are met:
- All bacterial strains must have demonstrated the required characteristics as determined by their respective strain checks according to Ames et al (1975),
Maron and Ames (1983) and Mortelmans and Zeiger (2000).
- All tester strain cultures should exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls.
(Acceptable ranges are presented in the report in the General Study Plan, Section 4 (negative controls)).
- All tester strain cultures should be in the range of 0.9 to 9 x 109 bacteria per ml.
- Diagnostic mutagens (positive control chemicals) must be included to demonstrate both the intrinsic sensitivity of the tester strains to mutagen exposure
and the integrity of the S9-mix. All of the positive control chemicals used in the study should induce marked increases in the frequency of revertant
colonies, both with or without metabolic activation.
- There should be a minimum of four non-toxic test item dose levels.
- There should be no evidence of excessive contamination.
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
positive
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: A test item precipitate (oily in appearance) was noted at 5000 µg/plate. Also a creamy film was observed at and above 1500 µg/plate.
Neither of these observations prevented the scoring of revertant colonies.

COMPARISON WITH HISTORICAL CONTROL DATA: Historical laboratory control data from 2010 and 2011 are documented in appendix 2 of the report
(History Profile of Vehicle and Positive Control Values)

ADDITIONAL INFORMATION ON CYTOTOXICITY: The test item caused no visible reduction in the growth of the bacterial background lawn at any dose level.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Tables below are from the original report:

Preliminary Toxicity Test:

The numbers of revertant colonies for the toxicity assay

S9-mix

Strain

Dose (µg/plate)

0

0.15

0.5

1.5

5

15

50

150

500

1500

5000

-

TA100

99

90

90

70

96

144

240

434

548

632F

804FP

+

TA100

91

76

86

90

88

122

155

229

323

644F

695FP

-

WP2uvrA

38

27

33

37

30

37

47

62

93

95F

124FP

+

WP2uvrA

34

45

34

37

45

34

60

36

45

56F

75FP

P: Test Item Precipitate; F: Test Item Film

Mutation Test Results: Experiment 1 – Without Metabolic Activation

Test Period

From: 29 June 2012

To: 02 July 2012

With or

Without

S9-Mix

Test

substance

concentration

(µg/plate)

Number of revertants (mean number of colonies per plate)

Base-pair substitution type

Frameshift type

TA100

TA1535

WP2uvrA

TA98

TA1537

-

0

103

103

108

(105)

2.9#

21

32

23

(25)

5.9

47

36

43

(42)

5.6

15

21

19

(18)

3.1

13

21

13

(16)

4.6

-

5

108

106

160

(125)

30.6

40

27

31

(33)

6.7

45

39

43

(42)

3.1

21

20

23

(21)

1.5

8

23

20

(17)

7.9

-

15

131

143

215

(163)

45.4

23

32

31

(29)

4.9

44

40

29

(38)

7.8

25

19

15

(20)

5.0

19

19

20

(19)

0.6

-

50

215

251

254

**

(240)

21.7

36

28

33

(32)

4.0

45

49

47

(47)

2.0

21

25

19

(22)

3.1

19

17

9

(15)

5.3

-

150

319

394

362

$$$

(358)

37.6

37

47

69

*

(51)

16.4

48

35

56

(46)

10.6

16

21

15

(17)

3.2

16

17

21

(18)

2.6

-

500

510

548

560

$$$

(539)

26.1

102

84

91

$$$

(92)

9.1

100

107

103

$$$

(103)

3.5

20

35

23

(26)

7.9

12

16

15

(14)

2.1

-

1500

464F

428F

478F

$$$

(457)

25.8

92F

83F

122F

$$$

(99)

20.4

107F

100F

90F

$$$

(99)

8.5

19F

20F

13F

(17)

3.8

11F

15F

15F

(14)

2.3

-

5000

954PF

560PF

668PF

$$$

(727)

203.6

120PF

104PF

182PF

$$$

(135)

41.2

71PF

80PF

68PF

$$$

(73)

6.2

17PF

20PF

19PF

(19)

1.5

13PF

16PF

13PF

äüö(14)

1.7

Positive

controls

- S9-Mix

Name

Concentration

(μg/plate)

No. colonies

per plate

ENNG

ENNG

ENNG

4NQO

9AA

3

5

2

0.2

80

521

477

444

(481)

38.6

271

303

273

(282)

17.9

748

875

830

(818)

64.4

135

115

146

(132)

15.7

452

707

462

(540)

144.4

ENNG: N-ethyl-N'-nitro-N-nitrosoguanidine; 4NQO: 4-Nitroquinoline-1-oxide; 9AA 9 -aminoacridine

P: Test Item Precipitate; F: Test Item Film

*: p <= 0.05; **:  p <= 0.01; $$$:  p <= 0.005; #: Standard deviation

Mutation Test Results: Experiment 1 – With Metabolic Activation

Test Period

From: 29 June 2012

To: 02 July 2012

With or Without
S9-Mix

Test

substance

concentration

(µg/plate)

Number of revertants (mean number of colonies per plate)

Base-pair substitution type

Frameshift type

TA100

TA1535

WP2uvrA

TA98

TA1537

+

0

88

90

92

(90)

2.0#

13

7

13

(11)

3.5

51

35

52

(46)

9.5

16

23

16

(18)

4.0

12

27

17

(19)

7.6

+

5

100

106

108

(105)

4.2

29

25

15

(23)

7.2

53

53

53

(53)

0.0

16

21

20

(19)

2.6

28

17

16

(20)

6.7

+

15

116

115

127

(119)

6.7

33

40

24

*

(32)

8.0

44

57

45

(49)

7.2

21

21

19

(20)

1.2

20

17

15

(17)

2.5

+

50

168

171

152

**

(164)

10.2

53

91

60

$$$

(68)

20.2

56

60

43

(53)

8.9

19

13

13

(15)

3.5

17

15

16

(16)

1.0

+

150

225

254

257

$$$

(245)

17.7

112

126

159

$$$

(132)

24.1

57

71

61

*

(63)

7.2

20

19

21

(20)

1.0

9

19

25

(18)

8.1

+

500

412

362

369

$$$

(381)

27.1

241

270

278

$$$

(263)

19.5

49

49

59

(52)

5.8

13

23

32

(23)

9.5

11

13

12

(12)

1.0

+

1500

640F

540F

597F

$$$

(592)

50.2

448F

366F

357F

$$$

(390)

50.1

72F

61F

65F

*

(66)

5.6

15F

24F

28F

(22)

6.7

9F

11F

19F

(13)

5.3

+

5000

1144PF

1040PF

839PF

$$$

(1008)

155.0

417PF

512PF

410PF

$$$

(446)

57.0

104PF

84PF

74PF

$$$

(87)

15.3

20PF

11PF

8PF

(13)

6.2

3PF

4PF

5PF

(4)

1.0

Positive

controls

+ S9-Mix

Name

Concentration

(μg/plate)

No. colonies

per plate

2AA

2AA

2AA

BP

2AA

1

2

10

5

2

1429

1387

1330

(1382)

49.7

305

295

289

(296)

8.1

424

394

404

(407)

15.3

156

199

188

(181)

22.3

178

186

215

(193)

19.5

2AA: 2-Aminoanthracene; BP: Benzo(a)pyrene

P: Test Item Precipitate; F: Test Item Film

*: p <= 0.05; **:  p <= 0.01; $$$:  p <= 0.005; #: Standard deviation

Conclusions:
Interpretation of results (migrated information):
positive with metabolic activation
positive without metabolic activation

The test item, Novares LR 600, was considered to be mutagenic under the conditions of this test.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (positive)

Additional information

Justification for classification or non-classification

Based on current findings, no classification for mutagenic potential is required.